Seesen, Germany

Annika Kraemer-Kuehl

USPTO Granted Patents = 6 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:

goldMedal4 out of 306 
 
Boehringer Ingelheim Vetmedica Gmbh
 patents
silverMedal1 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 2022-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Mind of Annika Kraemer-Kuehl

Introduction

Annika Kraemer-Kuehl, an accomplished inventor based in Seesen, Germany, has made significant contributions to the field of veterinary medicine through her innovative research. With a total of six patents to her name, she has focused her work on identifying and developing novel immunogenic compositions, particularly in relation to avian coronaviruses.

Latest Patents

Among her latest patents, Kraemer-Kuehl's work includes the development of an attenuated Infectious Bronchitis Virus (IBV) with extended cell culture and tissue tropism. This invention pertains to an IBV that has been deposited with the BVR of IZSLER under accession number DPS RE RSCIC 16. The invention also encompasses any descendant IBV and any form of IBV that exhibits all identifying characteristics of the deposited strain. Furthermore, Kraemer-Kuehl has developed a modified S1 subunit of the coronavirus spike protein, which involves a recombinant avian coronavirus spike protein or a fragment containing a mutation at amino acid position 267 to Cysteine. This modification is foundational for creating an immunogenic composition comprising an avian coronavirus with the altered spike protein.

Career Highlights

Throughout her career, Annika has been associated with Boehringer Ingelheim Vetmedica GmbH, where she has contributed her expertise in developing groundbreaking veterinary solutions. Her work has been pivotal in understanding and combating infectious diseases that affect poultry, thereby enhancing global food security.

Collaborations

Kraemer-Kuehl has collaborated with notable professionals in her field, including Hans-Christian Philipp and Thomas Min Stephan. These collaborations have fostered an environment of innovation and have led to significant advancements in the research and development of veterinary vaccines and immunogenic compositions.

Conclusion

Annika Kraemer-Kuehl stands out as a leading figure in veterinary medicine innovation. Her significant contributions, as evidenced by her patents and collaborations, continue to shape the landscape of research in avian diseases. As the field evolves, her work will undoubtedly remain integral in fostering healthier animal populations around the globe.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…